Retinoic acid signaling drives differentiation toward the absorptive lineage in colorectal cancer.

Biological sciences Cancer Cell biology Functional aspects of cell biology Oncology

Journal

iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038

Informations de publication

Date de publication:
17 Dec 2021
Historique:
received: 27 01 2021
revised: 18 08 2021
accepted: 11 11 2021
entrez: 8 12 2021
pubmed: 9 12 2021
medline: 9 12 2021
Statut: epublish

Résumé

Retinoic acid (RA) signaling is an important and conserved pathway that regulates cellular proliferation and differentiation. Furthermore, perturbed RA signaling is implicated in cancer initiation and progression. However, the mechanisms by which RA signaling contributes to homeostasis, malignant transformation, and disease progression in the intestine remain incompletely understood. Here, we report, in agreement with previous findings, that activation of the Retinoic Acid Receptor and the Retinoid X Receptor results in enhanced transcription of enterocyte-specific genes in mouse small intestinal organoids. Conversely, inhibition of this pathway results in reduced expression of genes associated with the absorptive lineage. Strikingly, this latter effect is conserved in a human organoid model for colorectal cancer (CRC) progression. We further show that RXR motif accessibility depends on progression state of CRC organoids. Finally, we show that reduced RXR target gene expression correlates with worse CRC prognosis, implying RA signaling as a putative therapeutic target in CRC.

Identifiants

pubmed: 34877501
doi: 10.1016/j.isci.2021.103444
pii: S2589-0042(21)01415-2
pmc: PMC8633980
doi:

Types de publication

Journal Article

Langues

eng

Pagination

103444

Informations de copyright

© 2021 The Author(s).

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Références

Nature. 2020 Oct;586(7828):275-280
pubmed: 33029001
Bioinformatics. 2016 Sep 15;32(18):2847-9
pubmed: 27207943
Annu Rev Pathol. 2011;6:345-64
pubmed: 21073338
Eur J Oral Sci. 1996 Feb;104(1):2-9
pubmed: 8653492
Cell Rep. 2018 Feb 6;22(6):1600-1614
pubmed: 29425513
Gastroenterology. 2007 Sep;133(3):887-96
pubmed: 17678919
Mol Syst Biol. 2018 Jun 26;14(6):e8227
pubmed: 29945941
Nat Rev Cancer. 2014 May;14(5):342-57
pubmed: 24705652
Nat Protoc. 2009;4(8):1184-91
pubmed: 19617889
Bioinformatics. 2011 Jan 15;27(2):270-1
pubmed: 21081511
Chem Pharm Bull (Tokyo). 1999 Dec;47(12):1778-86
pubmed: 10748721
Nat Commun. 2017 Jan 06;8:13824
pubmed: 28059064
PLoS Med. 2013;10(5):e1001453
pubmed: 23700391
Nature. 2009 May 14;459(7244):262-5
pubmed: 19329995
Cell Mol Life Sci. 2015 Apr;72(8):1559-76
pubmed: 25558812
Genome Biol. 2014;15(12):550
pubmed: 25516281
J Exp Med. 2020 Feb 3;217(2):
pubmed: 31753849
Bioinformatics. 2019 Jun 1;35(12):2084-2092
pubmed: 30395178
Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3551-6
pubmed: 18292227
Mol Aspects Med. 2012 Feb;33(1):63-76
pubmed: 22120429
FEBS J. 2020 Jan;287(1):53-72
pubmed: 31306552
Oncotarget. 2018 Jul 24;9(57):30979-30996
pubmed: 30123421
Nat Genet. 2019 May;51(5):777-785
pubmed: 30988513
J Med Chem. 2001 Jul 5;44(14):2298-303
pubmed: 11428923
Development. 2012 Mar;139(6):1071-82
pubmed: 22318232
Cancer Cell. 2015 Dec 14;28(6):815-829
pubmed: 26678341
Nat Rev Gastroenterol Hepatol. 2019 Jan;16(1):19-34
pubmed: 30429586
Gastroenterology. 2012 Feb;142(2):219-32
pubmed: 22155636
Mol Cell Biol. 1995 Sep;15(9):5131-43
pubmed: 7651430
Int J Mol Sci. 2018 Jan 03;19(1):
pubmed: 29301374
Nat Methods. 2013 Dec;10(12):1213-8
pubmed: 24097267
Bioorg Med Chem Lett. 2009 Feb 1;19(3):1001-3
pubmed: 19095448
Mol Cell Endocrinol. 2017 Dec 25;459:84-89
pubmed: 28342853
Development. 2019 Jul 4;146(13):
pubmed: 31273085
Genome Biol. 2008;9(9):R137
pubmed: 18798982
Nature. 2015 May 7;521(7550):43-7
pubmed: 25924068
Mucosal Immunol. 2018 May;11(3):703-715
pubmed: 29139475
Nature. 1996 Oct 3;383(6599):450-3
pubmed: 8837780
Sci Rep. 2019 Jun 27;9(1):9354
pubmed: 31249361
Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):E2357-E2364
pubmed: 28270604
J Exp Clin Cancer Res. 2019 Aug 1;38(1):334
pubmed: 31370857
Cell Mol Life Sci. 2010 May;67(9):1423-45
pubmed: 20140749
Biomolecules. 2019 Oct 04;9(10):
pubmed: 31590252
Nat Rev Mol Cell Biol. 2015 Feb;16(2):110-23
pubmed: 25560970
Nature. 2011 Sep 18;478(7368):255-9
pubmed: 21927002
Nature. 2017 Nov 16;551(7680):333-339
pubmed: 29144463
Cell. 2014 Mar 27;157(1):255-66
pubmed: 24679540
World J Gastrointest Oncol. 2015 Oct 15;7(10):184-203
pubmed: 26483874
J Biol Chem. 1996 May 24;271(21):12209-12
pubmed: 8647816
Oncotarget. 2018 Oct 5;9(78):34658-34669
pubmed: 30410666

Auteurs

Roelof A Wester (RA)

Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences (RIMLS), Oncode Institute, Radboud University Nijmegen, 6525GA Nijmegen, the Netherlands.

Lisa van Voorthuijsen (L)

Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences (RIMLS), Oncode Institute, Radboud University Nijmegen, 6525GA Nijmegen, the Netherlands.

Hannah K Neikes (HK)

Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences (RIMLS), Oncode Institute, Radboud University Nijmegen, 6525GA Nijmegen, the Netherlands.

Jelmer J Dijkstra (JJ)

Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences (RIMLS), Oncode Institute, Radboud University Nijmegen, 6525GA Nijmegen, the Netherlands.

Lieke A Lamers (LA)

Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences (RIMLS), Oncode Institute, Radboud University Nijmegen, 6525GA Nijmegen, the Netherlands.

Siebren Frölich (S)

Department of Molecular Developmental Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Nijmegen, 6525GA Nijmegen, the Netherlands.

Maarten van der Sande (M)

Department of Molecular Developmental Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Nijmegen, 6525GA Nijmegen, the Netherlands.

Colin Logie (C)

Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences (RIMLS), Oncode Institute, Radboud University Nijmegen, 6525GA Nijmegen, the Netherlands.

Rik G H Lindeboom (RGH)

Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences (RIMLS), Oncode Institute, Radboud University Nijmegen, 6525GA Nijmegen, the Netherlands.
Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.

Michiel Vermeulen (M)

Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences (RIMLS), Oncode Institute, Radboud University Nijmegen, 6525GA Nijmegen, the Netherlands.

Classifications MeSH